global-colorectal-cancer-screening-tests-market-industry
Published

November 2017

Global Colorectal Cancer Screening Tests Market - Industry Analysis and Market Forecast (2017 - 2022)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

Global Colorectal Cancer Screening Tests Market

The Global Colorectal Cancer Screening Tests Rate is to rise up to XX% by 2022. The growing incidences of colon and rectal cancer and the introduction of novel screening tests employing genetic testing are the major factors expected to drive the colorectal cancer screening tests market over the forecasted period. Demand for highly accurate and minimally invasive cancer screening tests is witnessed to increase R&D investments in colorectal cancer genetic screening tests. The global colorectal cancer screening tests market was found to be dominated by fecal occult blood tests owing to their higher usage rates and easy applicability to large groups of the population at once for cancer screening. However, the investigation and development of newer more accurate methods for colorectal cancer screening have led to the new development of DNA screening tests. This report provides the Colorectal Cancer Screening Tests Market Forecasting Model, offers valuable insights on global evolution, regional variation, and current market trends.

Drivers

  • Growing incidences of colon and rectal cancer
  • Introduction of novel screening tests
  • Advancements in the field of diagnosis  precision
  • Introduction of government regulations for screening
  • Increasing geriatric population
  • Strong Product Pipeline

Restraints

  • Stringent and ambiguous regulatory environment
  • Reimbursement challenges
  • Screening tests costs

Market Segmentation

The Global Colorectal Cancer Screening Tests market has been segmented based on tests that are Blood Tests, Fecal Tests, Colonoscopy and Flexible Sigmoidoscopy. The global Colorectal Cancer Screening Tests market has been segmented based on geography as North America, Europe, Asia-Pacific, Middle East and North Africa, and South America. Cancer is a developing concern inferable from rising elderly population and changes in way of life in Asian nations.

Some of the key players in this market include –

Some of the key players of this market are Abbott Diagnostics, Alere, Beckman Coulter, Companion Dx, Quest Diagnostics, Epigenomics Ag, Exact Sciences, Randox Laboratories, Genomic Tree, Siemens Healthcare and many more.

Key Deliverables

Market definition for the cardiac assist devices market, along with identification of key drivers and restraints for the market.

Market analysis for the Global Colorectal Cancer Screening Tests Market, with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.

Identification and analysis of the macro and micro factors that affect the global colorectal cancer screening tests market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

RELATED REPORTS
No related reports available.
Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?